BioCentury
ARTICLE | Clinical News

AeroVanc regulatory update

December 16, 2013 8:00 AM UTC

Savara said FDA granted Qualified Infectious Disease Product (QIDP) designation for AeroVanc to treat persistent methicillin-resistant Staphylococcus aureus (MRSA) lung infection in cystic fibrosis (C...